share_log

Marker Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Sep 8, 2018 05:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more